Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
The primary objective of this study is to evaluate if, in patients with severe obesity (body mass index (BMI) ≥30 kg/m2) and high-risk cardiovascular disease (CVD), bariatric surgery compared to medical weight management (MWM) safely reduces the risk of major cardiovascular events. The cost-effectiveness of bariatric surgery will also be examined. Separate sub-studies will be performed to examine the relationship between bariatric surgery and mental health and cognition (BRAVE-Mind), cardiac structure and function, genomics, proteomics and metabolomics.
Inclusion Criteria:
Body mass index ≥30 kg/m2; OR BMI ≥30 kg/m2 to 34.9 kg/m2 and have type 2 diabetes or are >55 years of age
Age ≥18 years
High-risk CVD, defined as the presence of any one of the following:
Exclusion Criteria:
jorge.wong@phri.ca905-521-2100 ext. 40309
sumathy.rangarajan@phri.ca905-296-5792